BT
Banque Transatlantique Portfolio holdings
AUM $3.63B
This Quarter Return
-6.84%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.31B
AUM Growth
-$622M
(-16%)
Cap. Flow
-$613M
Cap. Flow
% of AUM
-18.53%
Top 10 Holdings %
Top 10 Hldgs %
63.53%
Holding
279
New
14
Increased
40
Reduced
102
Closed
48
Top Buys
| 1 |
Boston Scientific
BSX
|
+$16.9M |
| 2 |
Motorola Solutions
MSI
|
+$10.7M |
| 3 |
Howmet Aerospace
HWM
|
+$9.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$9.04M |
| 5 |
Stryker
SYK
|
+$8.93M |
Top Sells
| 1 |
Spotify
SPOT
|
+$82.9M |
| 2 |
Microsoft
MSFT
|
+$68.4M |
| 3 |
Synopsys
SNPS
|
+$56.1M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
+$50.4M |
| 5 |
Amazon
AMZN
|
+$43M |
Sector Composition
| 1 | Technology | 39.2% |
| 2 | Healthcare | 16.39% |
| 3 | Consumer Discretionary | 12.59% |
| 4 | Consumer Staples | 9.52% |
| 5 | Communication Services | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Illumina
ILMN
$15.4B
| $5.71K | ﹤0.01% |
72
-590
| -89% | -$46.8K |
|
202
Recursion Pharmaceuticals
RXRX
$2.12B
| $4.89K | ﹤0.01% |
924
| – | – |
|
203
Align Technology
ALGN
$9.57B
| $4.61K | ﹤0.01% |
29
| – | – |
|
204
Embecta
EMBC
$886M
| $4.49K | ﹤0.01% |
352
-26
| -7% | -$331 |
|
205
Ametek
AME
$43.2B
| $4.3K | ﹤0.01% |
25
-183
| -88% | -$31.5K |
|
206
Expedia Group
EXPE
$27.7B
| $4.03K | ﹤0.01% |
24
-220
| -90% | -$37K |
|
207
Coinbase
COIN
$84B
| $3.62K | ﹤0.01% |
21
| – | – |
|
208
Agnico Eagle Mines
AEM
$76.5B
| $3.58K | ﹤0.01% |
33
| – | – |
|
209
Vontier
VNT
$6.21B
| $2.96K | ﹤0.01% |
90
-18
| -17% | -$591 |
|
210
Trade Desk
TTD
$22.3B
| $2.74K | ﹤0.01% |
50
-425
| -89% | -$23.2K |
|
211
Comcast
CMCSA
$119B
| $2.66K | ﹤0.01% |
72
| – | – |
|
212
Astronics
ATRO
$1.43B
| $2.42K | ﹤0.01% |
100
| – | – |
|
213
Astera Labs
ALAB
$39.7B
| $2.09K | ﹤0.01% |
35
-615
| -95% | -$36.7K |
|
|
MTLS
214
Materialise
MTLS
$298M
| $1.97K | ﹤0.01% |
400
| – | – |
|
215
ITT
ITT
$14.1B
| $1.94K | ﹤0.01% |
15
| – | – |
|
216
Organon & Co
OGN
$2.72B
| $1.71K | ﹤0.01% |
115
-20
| -15% | -$298 |
|
217
Teladoc Health
TDOC
$1.36B
| $1.27K | ﹤0.01% |
160
| – | – |
|
218
Hexcel
HXL
$4.98B
| $1.15K | ﹤0.01% |
21
| – | – |
|
219
AudioEye
AEYE
$166M
| $1.11K | ﹤0.01% |
+100
| New | +$1.11K |
|
220
Atara Biotherapeutics
ATRA
$82.2M
| $1.05K | ﹤0.01% |
176
| – | – |
|
|
GLDG
221
GoldMining Inc
GLDG
$241M
| $835 | ﹤0.01% |
1,000
| – | – |
|
222
Novavax
NVAX
$1.4B
| $769 | ﹤0.01% |
120
| – | – |
|
223
Esperion Therapeutics
ESPR
$554M
| $374 | ﹤0.01% |
260
| – | – |
|
224
Wabtec
WAB
$32.1B
| $363 | ﹤0.01% |
2
-13
| -87% | -$2.36K |
|
|
GRAL
225
GRAIL, Inc. Common Stock
GRAL
$1.4B
| $281 | ﹤0.01% |
11
| – | – |
|